
Georgia to expand COVID-19 testing, key to reaching ‘new norm’
By Alan Judd, The Atlanta Journal-Constitution | Photo: CURTIS COMPTON / AJC Georgia will dramatically expand testing for the novel coronavirus, following weeks of diagnostic
* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 10,000 tests per day.
Total Reported: 1,200,000+
Turnaround
0.5 Days
By Alan Judd, The Atlanta Journal-Constitution | Photo: CURTIS COMPTON / AJC Georgia will dramatically expand testing for the novel coronavirus, following weeks of diagnostic
APRIL 16, 2020 by Chris Worthy When Colin Rogers ’99 was majoring in history and playing football at Furman, having a hand in potentially slowing a
COO Lauren Bricks discusses Covid testing
This action is just one of many steps we are taking to keep our people safe from this dangerous virus. Expanding access to testing remains
By J. Scott Trubey, The Atlanta Journal-Constitution | Photos: Steve Schaefer FDA gives local lab OK Ipsum Diagnostics, in Sandy Springs, last week earned an
Ipsum Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has issued the Emergency Use Authorization (EUA) for their high capacity COVID-19 RT-PCR
Steven I. Marlowe MD FACP FIDSA Medical Director, Molecular Diagnostics New information on transmission and the uptick in cases in our local area prompt this
Ipsum Diagnostics, LLC, or other laboratories designated by Ipsum Diagnostics, LLC that are also certified under the ClinicalLaboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C.§263a,
By Max Blau Corrections officials are struggling to combat the rising spread of COVID-19 in prisons and jails throughout the state. The disease has led
8607 Roberts Drive
Suite 250
Atlanta, GA 30350
Phone: 678-915-2299
Fax: 844-364-8451
info@ipsumdiagnostics.com
Hours: Mon – Fri: 8am – 6pm
CAP No. 857023601 CLIA No. 11D2125186
Copyright © 2021 Ipsum Diagnostics. All Rights Reserved.